Saskia Klein

Zoekresultaten

• 2017

  Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)

  Huls, G., Chitu, D., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A., Biemond, B. J., Sinnege, H., Hodossy, B., Graux, C., Kooij, M. V. M., de Weerdt, O., Breems, D., Klein, S., Kuball, J., Ossenkoppele, G. J., Lowenberg, B. & Vellenga, E., 7-dec.-2017, In: Blood. 130, 3 blz.

  Onderzoeksoutput › Academic
• 2013

  Validation Of a Multi-Diagnostic Approach Including Flow Cytometry To Identify Specific Risk Categories Within Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

  Cremers, E. M. P., Westers, T. M., Alhan, C., Cali, C., Visser-Wisselaar, H. A., Chitu, D. A., Stevens-Kroef, M. J. P. L., Coelho, P. S., Vellenga, E., Klein, S. K., Wijermans, P. W., de Greef, G. E., Schaafsma, M. R., Kooy, M. M., Muus, P., Ossenkoppele, G. J., Jansen, J. H. & van de Loosdrecht, A. A., 15-nov.-2013, In: Blood. 122, 21, 2 blz.

  Onderzoeksoutput › Academic